【摘 要】
：
Aims：The goal of cell transcription for treatment of diabetes is to generate surrogateβ-cells from an appro—pilate cell line.However,the induced replacement cells have showed less physiological functi
【机 构】
：
Department of General Surgery，Affiliated Hospital of Nantong University，Nantong 22600 1，China Depart
【出 处】
：
2012国际肝胆胰外科昆山论坛暨第24届肝胆胰外科学术经验交流会
论文部分内容阅读
Aims：The goal of cell transcription for treatment of diabetes is to generate surrogateβ-cells from an appro—pilate cell line.However,the induced replacement cells have showed less physiological function in producing in—sulin compared with normal β-cells.Methods：Here,we report a procedure for induction of insulin-producing.cells(IPCs)from bone ma/Tow murine mesenehymal stem cells(BM-mMSCs).These BM-mMSCs have the poten—tial to differentiate into insulin—producing cells when a combination of PDX-1(pancreatic and duodenal home—obox—1),NeuroDl(neurogenic differentiation-1)and MafA(V-maf musculoaponeurotic fibrosarcoma oncogenehomogog A)genes are transfected into them and expressed in these cells。Results：Insulin biosynthesis and seere—tion were induced in mMSCs into which these three genes have been transfected and expressed。The amount ofinduced insulin in the mMSCs which have been tranfected with the three genes together is significantly higherthan in those mMSCs that were only transfected with one or two of these three genes.Transplantation of the trans—feeted cells into mice with streptozotoein—induced diabetes results in insulin expression and the reversal of theglucose challenge.Conclusions：These findings suggest major implications for cell replacement strategies in gen—eration of surrogate β-cells for the treatment of diabetes.
其他文献
RNA干扰技术可抑制目的基因的表达，具有高序列特异性，高效性，可传播性和浓度依赖性。其通过沉默癌基因，促进癌细胞凋亡，发挥治疗恶性肿瘤的优势。RNA干扰技术可应用于肝细胞癌发生、发展和转移等任何有基因高表达的环节，如点突变激活的癌基因、插入基因、融合基因、肿瘤多药耐药基因、血管生长因子及其受体等都可以作为RNA干扰作用的靶点，抑制相关基因表达，促进凋亡，抑制端粒酶活性，减少转移与复发，发挥肝癌的治
目的：探讨胰腺癌组织中低氧诱导因子-1α(HIF-1α)、血管内皮生长因子(VEGF)、VEGF 受体1(VEGFR1/Flt-1)、受体2(VEGFR2/Flk-1)对胰腺癌微血管密度(MVD)的影响及这些蛋白的表达与根治性手术后胰腺癌患者生存期的关系。方法：收集2002至今我院50例行胰十二指肠切除术胰腺癌患者的病理标本,免疫组化检测HIF-1α、VEGF、VECFR1、VEGFR2的表达。以
Gallbladder carcinoma;Angiogenesis;Llymphangiogensis;Survival analysis;Abbreviations;LMVD;lymphatic microvessels density;MVD;microvessels density Objective Lymphangiogenesis and angiogenesis are essen
目的：腹腔镜肝叶切除术中出血控制仍是一大难题,多年来我们应用选择性半肝血流阻断技术在腹腔镜肝切除术中控制失血起到较好作用,但其解剖繁琐,易伤及血管反致大出血。本研究应用Habib 4X双极射频辅助腹腔镜无血切肝,以了解其术中表现及术后并发症情况。方法：2007年1月～2012年2月,我科完成180例腹腔镜肝叶切除术,其中2009年9月起选择30例肝边缘性病灶病例行Habib 4X射频消融辅助切肝术
目的：随着社会人群的医疗卫生的防范意识的增强，人群普查或伴有轻微肠道症状来医院进行电子大肠镜检查而被发现早期大肠癌的患者人数近几年快速增长。在剖腹手术中可能遇到腹腔探查无法发现肿瘤，在手术中应用电子大肠镜检查定位可以起到理想的效果。方法：由于肿瘤早期，质地较软，可能难以触及。这时可以在术中立即进行电子结肠镜检查，找到肿瘤所在部位，术者在腹腔内找到镜端，也就找到肿瘤并进行缝线定位。结果：自2005年
目的：探讨术中电凝功率的不同对小切口胆囊切除术(MC)术后血清谷丙转氨酶(ALT)、谷草转氨酶(AST)的影响。方法：120例胆囊结石伴慢性胆囊炎病人随机分为2组(各60例),A组于术中切除胆囊时应用低电凝功率(40W),B组应用高电凝功率(90W)。结果：两组术后ALT、AST升高明显,与术前比较差异有显著性意义。A组术后ALT与B组比较无差异,但术后AST值比较有显著性意义。结论：小切口胆囊切
Acute pancreatitis(AP)is well-known to induce the injuries to extrapancreafic organs.Because respiratorydysfunction is the main cause of death in patients with severe AP,acute pancreatitis-associated
Purpose：To evaluate the effects of different-time ischemic preconditioning (TPC)schemes on the ischemi-.a-reperfusion(I/R)injury in moderate to severe hepatocirrhosis in rats and to identify the optim
目的：利用纳米技术研制索拉非尼纳米药物,观察其理化特性与抗肝癌作用。方法：采用纳米沉淀法制备索拉非尼载药纳米粒,采用纳米粒度及zeta电位仪(Nano-ZS ZEN3600,Malvem)测定载药纳米粒粒径与表面电位,紫外分光光度计测定索拉非尼的载药量与包封率,体外透析法测定索拉菲尼纳米微粒的释药缓释性。体外培养肝癌细胞H22,利用CCK8间接测定索拉非尼纳米药物对肝癌细胞增殖的影响。结果：索拉非
目的：观察沉默缺氧诱导因子-1a(HIF—1a)对肝癌(HepG2)细胞增殖的影响。方法：按照HIF-1a基因库序列合成针对HIF-1a的miRNA,转染HepG2细胞,在细胞培养的不同时段,以荧光定量-PCR和Western Blot分别检测HIF-la转录和蛋白表达,观察其干扰效率；并以miRNA转染HepG2细胞联合阿霉素后,流式细胞仪检测沉默HIF-la对HepG2细胞增殖的影响。结果：H